Scynexis (SCYX) Revenue Growth (3y) (2016 - 2025)
Scynexis (SCYX) Revenue Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 2.94% |
| 10 | Scynexis | 23.19 Mn | -13.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 130.43% |
| Sep 30, 2025 | -40.14% |
| Jun 30, 2025 | 1.02% |
| Mar 31, 2025 | -28.39% |
| Dec 31, 2024 | 17.84% |
| Sep 30, 2024 | 8.55% |
| Mar 31, 2024 | -51.52% |
| Jun 30, 2022 | 185.25% |
| Mar 31, 2022 | 121.98% |
| Dec 31, 2021 | 110.51% |
| Sep 30, 2021 | 100.52% |
| Mar 31, 2021 | 473.15% |
| Jun 30, 2019 | -3.79% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -0.52% |
| Dec 31, 2017 | -60.82% |
| Sep 30, 2017 | 1.61% |